| Authors: |
Hill K; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA. k.hill@yale.edu., Biegacki ET; Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, USA.; Department of General Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Bogut G; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., Znamierowski E; Department of General Internal Medicine, Yale School of Medicine, New Haven, CT, USA.; New Haven Syringe Services Program, New Haven, CT, USA.; Infectious Diseases, Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Breen C; Liberation Programs, Bridgeport, CT, USA., Rose R; Connecticut Harm Reduction Alliance, Hartford, CT, USA., Zhang C; Alliance for Living, New London, CT, USA., Grau LE; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., Butner JL; Department of General Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Heimer R; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., Sue KL; Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, USA.; Department of General Internal Medicine, Yale School of Medicine, New Haven, CT, USA. |
